FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/10/2022
Voltar para busca
Dado oficial do USPTO
BIOARCTIC
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
BIOARCTIC
ST13
US500000079309164Classe
1, 5, 10, 42, 44, 45
Pedido
79309164
Registro
6749255
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
38
Atualização mais recente
10/10/2022
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 10, 42, 44, 45
Data de depósito
14/12/2020
Data de registro
07/06/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
07/06/2022
Última transação
10/06/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
09
Localização do titular
SE
Examinador
BURKE, JUSTINE
Unidade examinadora
N30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
BioArctic AB
Representantes
Jessica S. Sachs Harness, Dickey & Pierce, PLC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 10Classe 42Classe 44Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemical substanceschemical materialschemical preparationsnon-synthetic elements for use in the manufacture of pharmaceuticals; chemical substances and materials for industrialscientific and laboratory useother than for medical or veterinary purposes; biochemical preparations for scientific purposes for use in the manufacture of pharmaceuticals; chemical substances for use in the production of drugspharmaceuticals and antibodies; reagents for scientificlaboratoryanalysisresearchmedical researchtestinginspectiondetecting or verification useother than for medical purposes; reagents for scientific or medical research use for use in the development of antibodiesother than for medical or veterinary purposes; reagents for scientific or medical research use for use in scientific apparatus for chemical or biological analysis; stem cells and reconstituted cells for research or scientific purposes; reconstituted cells for the efficiency and tolerance testing of pharmaceutical products for research or scientific purposes; antibodies and antibodies-based chemicalsfor use in industry and scienceexcept for medical or veterinary use; biological preparation for use in cell cultures other than for medical or veterinary use; all of the foregoing for use in the manufacture of pharmaceuticals
Classe 5
Medical and veterinary preparations for the treatment of neurodegenerative disorders; medical and veterinary articlesdiagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testing; pharmaceutical preparations and substances for the treatment of neurodegenerative disorders; biochemical preparations for medical use for the treatment of neurodegenerative disorders; pharmaceutical preparations and medical preparations for the treatmentprevention and diagnosis of Alzheimer's diseaseParkinson's disease and other neurodegenerative diseases and disorders of the central nervous system; antibodies and antibodies-based pharmaceutical preparations for medical purposes; diagnostic preparations for medical or veterinary purposes; medical therapeutic agents for neurodegenerative disorders; reagents for medical use; diagnostic biochemical biomarker reagents for medical use; diagnostic biomarker reagents for medical purposes; live organs and tissues for surgical implantation purpose; cells for medical use; stem cells for medical purposes; sanitary preparations for medical purposes; dietetic substancesdietetic foods adapted for medical purposes; diagnostic materialsdiagnostic kits consisting primarily of probesbuffersreagents for use in testing for neurological disorders and central nervous system disorders
Classe 10
Medical and veterinary apparatus and instrumentssyringes for medical purposessyringes for injectionshypodermic syringes; medical imaging apparatus; medical apparatus and devices for the diagnosis and treatment of neurological disorders and central nervous system disorders
Classe 42
Scientific and technological servicesscientific research and product development and designin the field of neurodegenerative disorders; medical and pharmacological research services; medicalpharmaceutical and biotechnological laboratory research services; scientific investigations for medical purposes; medical and scientific servicesnamely medical and scientific research services in the field of the central nervous systembrain disorders and central nervous system related disordersdiseases and pharmaceuticals; medical and scientific research in the field of neurological and neurodegenerative diseases; conducting clinical trials for others; providing scientific information about the results of clinical trials for pharmaceutical products; biochemical analysis and research; drug discovery services; pharmaceutical products development and evaluation
Classe 44
Human healthcare services; medical services; providing medical information; physical examination services; rental of medical machines and apparatus; providing information relating to the rental of medical machines and apparatus; medical diagnostic testing services; optical imaging for medical diagnostic use being medical imaging services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical testing for diagnostic or treatment purposes
Classe 45
Legal services; licensing of research and development methods; licensing of intellectual property
Publicações
Histórico de despachos e eventos da marca no USPTO.
38 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
16/09/2022
FIMP
FINAL DISPOSITION PROCESSED
16/09/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/09/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/06/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
07/06/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
17/05/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
17/05/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
17/05/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
17/05/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
17/05/2022
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
29/04/2022
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
01/04/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15/02/2022
PUBO
PUBLISHED FOR OPPOSITION
15/02/2022
GPNX
NOTIFICATION PROCESSED BY IB
14/02/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
26/01/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
26/01/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26/01/2022
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/01/2022
ALIE
ASSIGNED TO LIE
11/01/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/01/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
10/01/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/01/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
10/01/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/01/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/12/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/12/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/12/2021
RFNT
REFUSAL PROCESSED BY IB
05/07/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/06/2021
RFRR
REFUSAL PROCESSED BY MPU
11/06/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/06/2021
CNRT
NON-FINAL ACTION WRITTEN
07/06/2021
DOCK
ASSIGNED TO EXAMINER
07/06/2021
MAFR
APPLICATION FILING RECEIPT MAILED
27/04/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
23/04/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
22/04/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BIOARCTIC ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.